– Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. Cell Genomics, 2022;2(10):100192.
– Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases. Cell Genomics, 2022;2(10):100195.
– A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis. Cell Genomics, 2022;2(10):100190.
– Best practices for multi-ancestry, meta-analytic transcriptome-wide association studies: Lessons from the Global Biobank Meta-analysis Initiative. Cell Genomics, 2022;2(10):100180.
– Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits. Cell Genomics, 2022; DOI: https://doi.org/10.1016/j.xgen.2022.100189.
Oportunidades y potencialidades de biobancos
Filed under Diagnóstico, Genómica, Polimorfismos, Transcriptómica by on .
You must be logged in to post a comment. Login.
Leave a Comment